Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scholar Rock IncfiledCriticalScholar Rock Inc
Publication of AR115755A1publicationCriticalpatent/AR115755A1/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Peptides Or Proteins
(AREA)
Abstract
En el presente documento se describen anticuerpos monoclonales y fragmentos de unión a antígeno de los mismos capaces de inhibir selectivamente TGFb1 con alta potencia. Composiciones relacionadas, métodos y usos terapéuticos también se describen.Monoclonal antibodies and antigen-binding fragments thereof capable of selectively inhibiting TGF-1 with high potency are described herein. Related compositions, methods, and therapeutic uses are also described.
ARP190101955A2018-07-112019-07-11
ISOFORM SELECTIVE HIGH AFFINITY TGFb1 INHIBITORS AND THEIR USES
AR115755A1
(en)